Citation: | WU Xufeng, CHAI Shiying, LIU Jianhong, WANG Zhihui, YIN Ruifeng, CAO Ruiwei, SUN Xinqiang. Improvement of synthetic route of brivudine[J]. Journal of China Pharmaceutical University, 2022, 53(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20220106 |
[1] |
. Chin J Clin (中国临床医生杂志),2003,31(5):4-5.
|
[2] |
Zhang B,Shen Q,Shi Q. Clinical observation of treating post-acute zoster pain by ganglioside M1[J]. Med J Wuhan Univ (武汉大学学报 医学版),2017,38(5):790-793.
|
[3] |
Katz J,Cooper EM,Walther RR,et al. Acute pain in Herpes zoster and its impact on health-related quality of life[J]. Clin Infect Dis,2004,39(3):342-348.
|
[4] |
Lin JY,Chen QM,Zhou HM. Research progress of antiherpes virus drugs[J]. Chin J Stomatol(中华口腔医学杂志),2006,41 (1):60-62.
|
[5] |
Liu WG,Guo RL,Chen ZJ. New selective anti-herpes virus drug:(E)-5-(2-bromovinyl)2′-deoxyuridine[J]. Chin J Exp Ophthalmol (中华实验眼科杂志),1985,3(2):123-126.
|
[6] |
Clereq ED. (E)-5-(2-Bromovinyl)-2′-deoxyuridine (BVDU)[J]. Med Res Rev,2005,25 (1):1-20.
|
[7] |
Wassilew S,Collaborative Brivudin PHN Study Group. Brivudin compared with famciclovir in the treatment of Herpes zoster:effects in acute disease and chronic pain in immunocompetent patients. A randomized,double-blind,multinational study[J]. J Eur Acad Dermatol Venereol,2005,19(1):47-55.
|
[8] |
Mao F,Wu ZX,Zhang L,et al. Therapeutic effect of bromovudine on 37 cases of herpes zoster[J]. Mod Pract Med (现代实用医学),2018,30 (4):535-536.
|
[9] |
Barr PJ,Clereq ED,Jones AS,et al. E-
5-(2-halogenvinyl)-2′-desoxyuridine und deren verwendung als arzneimittel: DE2915254C2[P]. |
[10] |
Barr PJ,Jones AS,Verhelst G,et al. Synthesis of some 5-halogenovinyl derivatives of uracil and their conversion into 2′-deoxyribonucleosides[J]. J Chem Soc,Perkin Trans 1,1981:1665-1670.
|
[11] |
Szabolcs A,Otvos L,Sagi J,et al. Process for the preparation of (E)-
5-(2-bromovinyl)-2′-deoxyuridine and new derivatives thereof: GB2125399B[P]. |
[12] |
Aldo S,Alberto MC,Stefano M,et al. Process for the preparation of (E)-
5-(2-bromovinyl)-2′-deoxyuridine: WO2002068443A1[P]. |
[13] |
Zhang WB,Xie F,Wang CJ. Method for the preparation of bromovudine:
CN101066987B[P]. |
[14] |
Ashwell M,Jones AS,Kumar A,et al. The synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2′-deoxyuridine-related compounds[J]. Tetrahedron,1987,43(20):4601-4608.
|
[15] |
Asakura J,Robins MJ. Cerium(IV)-mediated halogenation at C-5 of uracil derivatives[J]. J Org Chem,1990,55(16):4928-4933.
|
[16] |
Jones AS,Verhelst G,Walker RT. The synthesis of the potent anti-Herpes virus agent,E-5(2-bromovinyl)-2′-deoxyuridine and related compounds[J]. Tetrahedron Lett,1979,20(45):4415-4418.
|
[17] |
Kassis AI,Foulon CF,James Adelstein S. Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides:
US5574148[P]. |
[18] |
Chinese Pharmacopoeia Commission.
|
[19] |
Kumar R,Wiebe LI,Knaus EE. A mild and efficient methodology for the synthesis of 5-halogeno uracil nucleosides that occurs via a 5-halogeno-6-azido-5,6-dihydro intermediate[J]. Can J Chem,1994,72(9):2005-2010.
|
[20] |
Eger K,Jalalian M,Schmidt M. Steric fixation of bromovinyluracil:synthesis of furo[2,3-d]pyrimidine nucleosides[J]. J Heterocycl Chem,1995,32(1):211-218.
|
[1] | LIU Li, LIU Zijin, TANG Jun, HE Guangwei, LIU Weizhong. Optimized synthesis process of tofacitinib citrate[J]. Journal of China Pharmaceutical University, 2022, 53(6): 685-689. DOI: 10.11665/j.issn.1000-5048.20220606 |
[2] | WANG Dong, ZHONG Jian, WANG Ling, ZHOU Zhihui, JIANG Haiting, LUO Peng, WANG Xizhi, WANG Chongyi. Improved synthetic process of apremilast[J]. Journal of China Pharmaceutical University, 2021, 52(5): 536-540. DOI: 10.11665/j.issn.1000-5048.20210504 |
[3] | HAN Chengqun, ZOU Qiaogen, SUN Qian, XIA Yunyan. Improvement of synthesis process of mirabegron[J]. Journal of China Pharmaceutical University, 2020, 51(4): 449-453. DOI: 10.11665/j.issn.1000-5048.20200409 |
[4] | ZHANG Qiuyue, YOU Qidong, YANG Jinpeng. Process improvement on the synthesis of atomoxetine[J]. Journal of China Pharmaceutical University, 2019, 50(4): 405-409. DOI: 10.11665/j.issn.1000-5048.20190404 |
[5] | LIU Li, WANG Chen, LIU Lixin, JI Tingting. Improved synthesis of analgesic pentazocine[J]. Journal of China Pharmaceutical University, 2018, 49(5): 568-571. DOI: 10.11665/j.issn.1000-5048.20180508 |
[6] | ZHANG Chunlai, LUO Hongjun, JIANG Qi, LI Guoxian, GU Guoqing, ZHANG Jie. Improved process of dexrabeprazole sodium[J]. Journal of China Pharmaceutical University, 2018, 49(3): 291-294. DOI: 10.11665/j.issn.1000-5048.20180306 |
[7] | MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106 |
[8] | WEI Qingjie, QIAO Junhua, CHEN Jianjun, GAO Zhigang, LI Yaqing. An improvement for synthesis of ceftriaxone sodium[J]. Journal of China Pharmaceutical University, 2016, 47(2): 163-165. DOI: 10.11665/j.issn.1000-5048.20160206 |
[9] | WU Jiaquan, ZHOU Ping, LIU Yang, JIE Chuanming, CAO Huanyan, PENG Tao, LI Xiaohong, ZHANG Haijun. An improved preparing process for rivastigmine[J]. Journal of China Pharmaceutical University, 2015, 46(4): 421-425. DOI: 10.11665/j.issn.1000-5048.20150406 |
[10] | Improve on the Synthetic Process of Bezafibrate[J]. Journal of China Pharmaceutical University, 2003, (3): 80-81. |